跳至主要内容
临床试验/TCTR20230821001
TCTR20230821001已完成2 期

Comparison Effectiveness of Melatonin and Clonidine in Treatment of Insomnia in Children with Attention Deficit Hyperactivity Disorder: Randomized Controlled Trial

Pramonkutklao Foundation0 个研究点目标入组 58 人开始时间: 2023年8月21日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
58

研究概览

简要总结

Children with attention-deficit/hyperactivity disorder with insomnia had shown benefit of sleep improvement by treating with both short-acting clonidine and prolonged-release melatonin without serious adverse effect.

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Years 至 12 Years(—)
性别
All

入选标准

  • Children aged 6-12 years old who met Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5) of Attention-Deficit/Hyperactivity Disorder (ADHD) and met criteria of chronic insomnia disorder from International Classification of Sleep Disorder third edition (ICSD 3rd edition)

排除标准

  • established diagnosis of autism spectrum disorder, intellectual disability, genetic syndrome, obstructive sleep apnea, adjusting dose of ADHD medication, ongoing insomnia treatment, allergic to clonidine or melatonin, using sedative agent and caregiver unable to record sleep diary

研究者

发起方
Pramonkutklao Foundation

相似试验